Previous close | 174.56 |
Open | 173.09 |
Bid | 174.71 x 200 |
Ask | 175.06 x 100 |
Day's range | 171.74 - 177.70 |
52-week range | 111.20 - 187.12 |
Volume | |
Avg. volume | 156,223 |
Market cap | 6.282B |
Beta (5Y monthly) | 1.28 |
PE ratio (TTM) | 102.33 |
EPS (TTM) | 1.71 |
Earnings date | 05 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 181.00 |
BEDFORD, Mass., October 08, 2024--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024.
Over the last 7 days, the market has risen 1.8%, and over the past 12 months, it is up 32%, with earnings forecast to grow by 15% annually. In this favorable environment, identifying high growth tech stocks that align with these robust trends can be crucial for investors looking to capitalize on market momentum.
Looking back on electronic components stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Novanta (NASDAQ:NOVT) and its peers.